New Launch13 Aug 2025, 11:55 am
Concord Biotech Celebrates 25+ Years of Excellence in Fermentation-Based API & Formulation, Showcasing Sustainable Innovation
AI Summary
Concord Biotech Ltd, in its annual report for the financial year 2024-25, highlights its commitment to sustainable innovation through fermentation-based API production. The company, with over 25 years of experience, has created a wide product portfolio of 30+, catering to 250+ customers across 70+ capacities in regulated markets and stringent global regulatory audits. The report emphasizes the company's dedication to reporting financial and non-financial performance in compliance with regulatory requirements, and its commitment to adopting best practices in corporate reporting.
Key Highlights
- Concord Biotech celebrates 25+ years of excellence in fermentation-based API & formulation
- The company has created a wide product portfolio of 30+, catering to 250+ customers
- Concord Biotech has a strong presence across 70+ capacities in regulated markets
- The company's fermentation-based API production leverages natural metabolic processes of microorganisms
- Concord Biotech is committed to reporting financial and non-financial performance in compliance with regulatory requirements